tiprankstipranks

BioNTech price target lowered to $110 from $122 at TD Cowen

TD Cowen lowered the firm’s price target on BioNTech (BNTX) to $110 from $122 and keeps a Hold rating on the shares. The firm updated its model following Q4 results as all eyes are now on its oncology pipeline.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue